People · Operator
Named in public records as an officer, director or promoter · active 2012–2013 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Rapid Pathogen Screening Inc | — | Biotechnology | Series B | $57.5M | $248.1M | 2012 |
Caroline T. Popper at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Caroline T. Popper on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| William D. Rueckert | 1 | 4 |
| Charles T. Saldarini | 1 | 3 |
| Douglas W. Berg | 1 | 2 |
| William Rueckert | 1 | 2 |
| Stephen R. La Neve | 1 | 2 |
| Michael Strauss | 1 | 2 |
| Daniel Sambursky | 1 | 1 |
| Jose Scott Sambursky | 1 | 1 |
| Jules Musinger | 1 | 1 |
| Thomas Orsini | 1 | 1 |
| Robert VanDine | 1 | 1 |
| J. Scott Womble | 1 | 1 |
| Robert Sambursky | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.